| Microbia, Inc. is a majority-owned subsidiary of Ironwood Pharmaceuticals, Inc.
Microbia is building a sustainable specialty biochemicals business based on their versatile, proprietary strain development platform. Driven by advances in genomics technology, volatile oil prices, and a growing interest in ecological sustainability, the world is increasingly turning to industrial biotechnology to create renewable sources of products for use in pharmaceuticals, foods, and specialty and industrial chemicals. Microbia’s validated technology platform enables them to produce high-quality, competitively-priced specialty ingredients and industrial biomaterials from renewable resources.
|